Abstract
The number of immunocompromised patients has increased over the past decades due to HIV infection, solid and stem cell transplantation, intensified chemotherapy and treatment of autoimmune disease. Pneumonia is a major cause of both morbidity and mortality in immunocompromised patients. Clinical management of pneumonia is difficult, since differential diagnosis in this setting is broad and includes both infectious and noninfectious processes. Because the development of pneumonia in immunocompromised patients is frequently life threatening, early therapeutic and diagnostic intervention is essential to obtain better outcomes. Copyright
| Original language | English |
|---|---|
| Pages (from-to) | 371-383 |
| Number of pages | 13 |
| Journal | Tuberculosis and Respiratory Diseases |
| Volume | 70 |
| Issue number | 5 |
| DOIs | |
| State | Published - 30 May 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Disease management
- Immunocompromised patient
- Pneumonia
Fingerprint
Dive into the research topics of 'Pneumonia in immunocompromised patients'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver